86 articles
A landmark 48-RCT Cochrane review finds high-certainty evidence that convalescent plasma does not reduce death in moderate-to-severe COVID-19.
A Cochrane meta-analysis of 8 RCTs finds most pharmacological treatments fail to improve ataxia scores, though upper limb dexterity may benefit.
Expert reviews of top CGM platforms reveal genuine metabolic insights — but no proof they extend lifespan in healthy adults.
A Dana-Farber review maps the path for personalized cancer vaccines — pinpointing which tumors, timing, and combination strategies will matter most.
Expert reviews compare NMN and NR on human trial data, bioavailability, and top-ranked brands for 2026.
A translational review outlines how stem cell technologies may finally make hepatocyte-based liver therapies clinically viable.
Six leading CGM platforms compared on accuracy, evidence quality, and longevity claims — most fall short of the hype.
A comparative review of NMN and NR supplements weighs tissue targeting, clinical evidence, and top-rated products for NAD+ optimization.
Burke and Noakes reach surprising common ground on fueling endurance sport, while key disagreements remain unresolved.
A major Lancet review argues that optimizing current depression treatments may be more impactful than developing new ones.
Continuous glucose monitors are popular in biohacking circles, but direct evidence linking CGM use to extended lifespan remains thin.
A scoping review exposes deep conceptual gaps in how physical resilience is defined and measured across aging and rehabilitation science.
